Tech Company Financing Transactions

TetraLogic Pharmaceuticals Funding Round

Latterell Venture Partners, Amgen Ventures and HealthCare Ventures joined a $36 million Series B funding round for TetraLogic Pharmaceuticals. The round was announced on 6/12/2006.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

343 Phoenixville Pike
Malvern, PA 19355
USA

Phone

(610) 889-9900

Website

www.tetralogicpharma.com

Email Address

[email protected]

Overview

TetraLogic Pharmaceuticals (NASDAQ: TLOG) discovers and develops novel, targeted drugs to treat cancer.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Kevin Buchi

        

Chief Financial Officer

Patrick Hutchison

        

Chief Medical Officer

Jeffrey Skolnik

        

Chief Scientific Officer

Stephen Condon

        

VP - General Counsel

Richard Sherman

        

VP - Operations

Tony Meehan

        

VP - R & D

Glenn Begley

        

Browse more venture capital transactions:

Prev: 6/12/2006: Allworx venture capital transaction
Next: 6/12/2006: SOA Software venture capital transaction

Share this article

News on VC Transactions

We report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary